ADHD Archives
Child Health Poll: more than 1-in-4 Tennessee parents worried their kids have undiagnosed depression, anxiety
May. 24, 2023—The latest analysis of the 2023 Tennessee Child Health Poll, released during National Mental Health Awareness Month, has found that roughly 29% of Tennessee parents are concerned their child has undiagnosed anxiety or depression.
Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment
Apr. 2, 2021—Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.
Nearly one-third of Tennessee parents are worried their child has an undiagnosed mental health condition, new poll finds
Jul. 16, 2020—One-third of Tennessee parents with children ages 6-17 are worried their child has an undiagnosed mental health condition, a new poll from the Vanderbilt Center for Child Health Policy found.
Defective transporter linked to autism
Jul. 24, 2019—A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder.
‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder
Oct. 23, 2014—The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.
U.S. Senate hearing explores ADHD treatment concerns
Feb. 27, 2014—William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD).
Neurotransmitter’s role in bone balance
Nov. 7, 2013—Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.
Transporter linked to autism risk
Sep. 19, 2013—Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
New clue to ADHD
May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
Minds wide open: Neuroscience at Vanderbilt
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Vanderbilt study finds no heart risk in ADHD medications
Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
